{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:28:57Z","timestamp":1787776137495,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.lpm.2008.03.013","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T09:19:14Z","timestamp":1216372754000},"page":"1327-1333","source":"Crossref","is-referenced-by-count":7,"title":["Agranulocytoses m\u00e9dicamenteuses idiosyncrasiques"],"prefix":"10.1016","volume":"37","author":[{"given":"Laure","family":"Federici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Weitten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Alt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Blaison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Zamfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Audhuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Maloisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Andr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2008.03.013_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andr\u00e8s","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ajh.20176","article-title":"Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study","volume":"77","author":"Andersohn","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/14740338.6.3.323","article-title":"Non-chemotherapy drug-induced agranulocytosis","volume":"6","author":"Garbe","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.lpm.2008.03.013_bib5","first-page":"257","article-title":"Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drugs induced blood cytopenias: a report of an international consensus meeting","volume":"33","author":"Benichou","year":"1993","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.3.5875.339","article-title":"Drug-induced blood dyscrasias in Sweden","volume":"3","author":"B\u00f6ttiger","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.lpm.2008.03.013_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.0954-6820.1979.tb06084.x","article-title":"Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee","volume":"205","author":"B\u00f6ttiger","year":"1979","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.lpm.2008.03.013_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.0954-6820.1982.tb03216.x","article-title":"Drug-induced neutropenia--a survey for Stockholm 1973\u201378","volume":"212","author":"Arneborn","year":"1982","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.lpm.2008.03.013_bib9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","article-title":"A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study","volume":"256","author":"Risks of agranulocytosis and aplastic anemia","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2008.03.013_bib10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archinte.1992.00400190095018","article-title":"Descriptive epidemiology of agranulocytosis","volume":"152","author":"Strom","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archinte.159.4.369","article-title":"A population-based case-cohort study of drug-associated agranulocytosis","volume":"159","author":"van der Klauw","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0895-4356(98)00072-9","article-title":"Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use","volume":"51","author":"Rawson","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"Suppl","key":"10.1016\/j.lpm.2008.03.013_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.1996.tb01644.x","article-title":"Drug-related blood dyscrasias in a Swedish reporting system, 1985\u20131994","volume":"60","author":"Wiholm","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.1999.60.573","article-title":"Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence","volume":"60","author":"Shapiro","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lpm.2008.03.013_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/B:EJEP.0000032371.97823.85","article-title":"Incidence of agranulocytosis in Southwest France","volume":"19","author":"Th\u00e9ophile","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.lpm.2008.03.013_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajh.10295","article-title":"Neutropenia and agranulocytosis in England and Wales: incidence and risk factors","volume":"72","author":"van Staa","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","article-title":"Population-based drug-induced agranulocytosis","volume":"165","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0953-6205(02)00085-7","article-title":"Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature","volume":"13","author":"Andr\u00e8s","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib19","series-title":"The drug etiology of agranulocytosis and aplastic anemia","year":"1991"},{"key":"10.1016\/j.lpm.2008.03.013_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejim.2006.07.012","article-title":"Idiosyncratic drug-induced agranulocytosis: Update of an old disorder","volume":"17","author":"Andr\u00e8s","year":"2006","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00002018-199411060-00006","article-title":"Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance","volume":"11","author":"Patton","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.lpm.2008.03.013_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.297.6643.262","article-title":"Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study","volume":"297","author":"cvc","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2008.03.013_bib23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/archinte.1989.00390050040008","article-title":"Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study","volume":"149","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib25","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.3324\/haematol.11031","article-title":"Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery","volume":"92","author":"Terrier","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2008.03.013_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2257.2002.00437.x","article-title":"Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature","volume":"24","author":"Andr\u00e8s","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.1989.tb07672.x","article-title":"Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies","volume":"72","author":"Salama","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V69.2.394.394","article-title":"Chlorpropamide-induced pure white cell aplasia","volume":"69","author":"Levitt","year":"1987","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.lpm.2008.03.013_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0609.1996.tb01648.x","article-title":"Immune mechanisms leading to drug-induced blood dyscrasias","volume":"60","author":"Claas","year":"1996","journal-title":"Eur J Haematol"},{"issue":"Suppl","key":"10.1016\/j.lpm.2008.03.013_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.1996.tb01651.x","article-title":"Reactive metabolites and agranulocytosis","volume":"60","author":"Uetrecht","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1054\/mehy.1998.0734","article-title":"Drugs that induce neutropenia\/agranulocytosis may target specific components of the stromal cell extracellular matrix","volume":"53","author":"Guest","year":"1999","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.lpm.2008.03.013_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/01.jcp.0000144891.52858.a6","article-title":"Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis","volume":"24","author":"Mosyagin","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.lpm.2008.03.013_bib33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0022-3565(24)37177-0","article-title":"Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis","volume":"283","author":"Williams","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lpm.2008.03.013_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/mol.58.1.207","article-title":"Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine","volume":"58","author":"Williams","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.lpm.2008.03.013_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archpsyc.58.1.93","article-title":"Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample","volume":"58","author":"Dettling","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lpm.2008.03.013_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00008571-200103000-00004","article-title":"Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry","volume":"11","author":"Dettling","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.lpm.2008.03.013_bib37","first-page":"1495","article-title":"About specific sore throat","volume":"48","author":"Schultz","year":"1922","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.lpm.2008.03.013_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00002512-200421070-00002","article-title":"Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients","volume":"21","author":"Andr\u00e8s","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.lpm.2008.03.013_bib39","first-page":"470","article-title":"Prognostic factors of hematologic recovery in nonchemotherapy drug-induced agranulocytosis","volume":"88","author":"Maloisel","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2008.03.013_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00063030-199911030-00005","article-title":"Treatment of drug-induced agranulocytosis with haematopoietic growth factors: a review of the clinical experience","volume":"11","author":"Vial","year":"1999","journal-title":"BioDrugs"},{"key":"10.1016\/j.lpm.2008.03.013_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.1991.tb08042.x","article-title":"Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes","volume":"79","author":"Juli\u00e1","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2008.03.013_bib42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0755-4982(04)98884-7","article-title":"Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis. A study of 91 patients from a single center","volume":"33","author":"Maloisel","year":"2004","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00002018-200326100-00003","article-title":"Drug-induced myelosuppression: diagnosis and management","volume":"26","author":"Carey","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.lpm.2008.03.013_bib44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2008.03.013_bib45","unstructured":"http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/fever.pdf. National comprehensive cancer network: NCCN Clinical Practice. Guidelines in Oncology. Fever and neutropenia. 2006."},{"key":"10.1016\/j.lpm.2008.03.013_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1592\/phco.19.4.299.30941","article-title":"Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colony-stimulating factors","volume":"19","author":"Beauchesne","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.lpm.2008.03.013_bib47","first-page":"2031","article-title":"The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases","volume":"8","author":"Sprikkelman","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.lpm.2008.03.013_bib48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9343(02)01064-1","article-title":"Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor","volume":"112","author":"Andr\u00e8s","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2008.03.013_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/qjmed\/94.8.423","article-title":"Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis","volume":"94","author":"Andr\u00e8s","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.lpm.2008.03.013_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1999.9.29","article-title":"Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study","volume":"9","author":"Fukata","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2008.03.013_bib51","article-title":"Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.lpm.2008.03.013_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2005.06.008","article-title":"Idiosyncratic drug-induced agranulocytosis","volume":"27","author":"Andr\u00e8s","year":"2006","journal-title":"Rev Med Interne"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498208003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T02:22:27Z","timestamp":1738290147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498208003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0755498208003588"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2008.03.013","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}